Cencora (NYSE:COR) CEO Sells $1,665,699.60 in Stock

Cencora, Inc. (NYSE:COR) CEO Robert Mauch sold 5,097 shares of the business’s stock in a transaction on Monday, October 20th. The shares were sold at an average price of $326.80, for a total transaction of $1,665,699.60. Following the transaction, the chief executive officer owned 37,940 shares in the company, valued at $12,398,792. This trade represents a 11.84% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Cencora Trading Down 0.6%

COR stock opened at $328.98 on Friday. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 3.64. Cencora, Inc. has a twelve month low of $223.92 and a twelve month high of $331.94. The stock has a market capitalization of $63.78 billion, a price-to-earnings ratio of 33.85, a price-to-earnings-growth ratio of 1.55 and a beta of 0.63. The firm’s fifty day simple moving average is $303.30 and its two-hundred day simple moving average is $294.47.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $4.00 earnings per share for the quarter, beating analysts’ consensus estimates of $3.79 by $0.21. The business had revenue of $80.66 billion for the quarter, compared to analysts’ expectations of $80.34 billion. Cencora had a net margin of 0.60% and a return on equity of 267.36%. The business’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.34 earnings per share. As a group, analysts anticipate that Cencora, Inc. will post 15.37 earnings per share for the current year.

Cencora Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 3rd. Stockholders of record on Friday, August 15th were issued a $0.55 dividend. The ex-dividend date was Friday, August 15th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.7%. Cencora’s dividend payout ratio is presently 22.63%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on COR shares. Weiss Ratings restated a “buy (b)” rating on shares of Cencora in a report on Wednesday, October 8th. Wells Fargo & Company upped their price target on shares of Cencora from $337.00 to $354.00 and gave the stock an “overweight” rating in a report on Wednesday, August 13th. Evercore ISI set a $340.00 price target on shares of Cencora in a report on Wednesday, October 8th. Jefferies Financial Group upped their price target on shares of Cencora from $275.00 to $300.00 and gave the stock a “hold” rating in a report on Monday, June 30th. Finally, Morgan Stanley set a $330.00 price target on shares of Cencora and gave the stock an “equal weight” rating in a report on Wednesday, July 16th. Nine equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $324.91.

Institutional Trading of Cencora

A number of hedge funds have recently added to or reduced their stakes in COR. Atlantic Edge Private Wealth Management LLC lifted its stake in Cencora by 70.0% in the second quarter. Atlantic Edge Private Wealth Management LLC now owns 85 shares of the company’s stock worth $25,000 after acquiring an additional 35 shares during the period. Cornerstone Planning Group LLC lifted its position in shares of Cencora by 106.7% during the first quarter. Cornerstone Planning Group LLC now owns 93 shares of the company’s stock valued at $26,000 after buying an additional 48 shares during the last quarter. Costello Asset Management INC purchased a new stake in shares of Cencora during the first quarter valued at about $28,000. Vermillion & White Wealth Management Group LLC lifted its position in shares of Cencora by 69.4% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock valued at $31,000 after buying an additional 43 shares during the last quarter. Finally, University of Texas Texas AM Investment Management Co. purchased a new stake in shares of Cencora during the first quarter valued at about $39,000. 97.52% of the stock is owned by hedge funds and other institutional investors.

Cencora Company Profile

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.